Tag: postpartum depression · Read Scott Alexander

How to avoid getting lost reading Scott Alexander and his 1500+ blog posts? This unaffiliated fan website lets you sort and search through the whole codex. Enjoy!

Highlights From The Comments On Zulresso

14 min • 1,804 words • 17 comments • 37 likes • podcast

Scott Alexander highlights and responds to expert comments on his previous posts about Zulresso and Zuranolone, covering various aspects of these drugs and related topics. Longer summary

Scott Alexander summarizes and responds to comments on his previous posts about Zulresso and Zuranolone. The post covers various topics including drug pricing, mechanism details of GABA receptors, etymology of drug names, tolerance development, progesterone's effects, and personal experiences with progesterone. Scott expresses appreciation for the expertise of his commenters, particularly in biomedical topics, and acknowledges learning new information from them. Shorter summary

Recurring tags: highlights from the comments (56), drug pricing (10), tolerance (5), postpartum depression (3), Zulresso (3), hormone therapy (3), drug mechanisms (3), progesterone (2), Zuranolone (2)

Mar 10, 2022

acx

Progesterone Megadoses Might Be A Cheap Zulresso Substitute

6 min • 693 words • 88 comments • 52 likes • podcast

Scott Alexander proposes using high-dose oral progesterone as a potential low-cost alternative to Zulresso for treating postpartum depression, based on pharmacological research. Longer summary

Scott Alexander explores the possibility of using high-dose progesterone as a cheaper alternative to Zulresso for treating postpartum depression. He explains that Zulresso is a metabolite of progesterone and presents research suggesting that a specific regimen of oral progesterone could potentially mimic the effects of Zulresso. The post discusses the pharmacokinetics, dosing schedule, and potential cost savings, with progesterone treatment costing only about $11 compared to Zulresso's $35,000. Scott acknowledges potential obstacles in implementation but hopes researchers will investigate this approach further. Shorter summary

Recurring tags: medical research (46), FDA (29), healthcare costs (18), Zulresso (3), drug mechanisms (3), postpartum depression (3), hormone therapy (3), progesterone (2)

Mar 08, 2022

acx

Zounds! It's Zulresso and Zuranolone!

28 min • 3,635 words • 117 comments • 70 likes • podcast

Scott Alexander examines Zulresso and Zuranolone, two neurosteroid drugs for postpartum depression, discussing their efficacy, challenges, and potential future applications. Longer summary

Scott Alexander discusses Zulresso (allopregnanolone) and Zuranolone, two related drugs for treating postpartum depression. He explains their mechanisms, efficacy, and the challenges in their development and usage. The post covers the history of allopregnanolone research, its connection to GABA and hormones, clinical trials, and potential future applications. Scott also discusses the high cost of Zulresso, its limited availability, and the mixed results of Zuranolone in treating regular depression and anxiety. The post ends with predictions about the future of these drugs and related research. Shorter summary

Recurring tags: drug development (12), clinical trials (11), drug pricing (10), FDA approval (5), Zulresso (3), postpartum depression (3), hormone therapy (3), GABA (2), Zuranolone (2)

Per page: